Iovance Biotherapeutics, Inc. announced that Wendy Dixon, Ph.D. who has been a member of Board of Directors since 2022, will not stand for re-election at the Annual Meeting, to be held on June 6, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.68 USD | -0.37% | -20.24% | +31.37% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.37% | 2.99B | |
-27.90% | 9.84B | |
-4.81% | 3.15B | |
-14.73% | 2.15B | |
-14.39% | 1.8B | |
+70.99% | 1.49B | |
+23.17% | 770M | |
-2.18% | 762M | |
+3.18% | 308M | |
+6.63% | 210M |
- Stock Market
- Equities
- IOVA Stock
- News Iovance Biotherapeutics, Inc.
- Iovance Biotherapeutics, Inc. Announces Wendy Dixon, Member of Board of Directors, Will Not Stand for Re-Election